Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II trial atezolizumab w/stage IIIA and IIIB NSCLC for chemoradiotherapy with curative intent

Protocol: OSU-17163

Full Title

Phase II trial of induction immunotherapy with atezolizumab for patients with unresectable stage IIIA and IIIB NSCLC eligible for chemoradiotherapy with curative intent.

Lung Cancers